Drugmakers have leverage and are getting 'a real negotiation' with the government over the prices of products selected under ...

Providence Health Plan, which mainly operates in Oregon as part of West Coast health system Providence, said it’s working ...

Roche on Thursday shared early positive results for its Alzheimer’s candidate trontinemab, the latest round of data in its ...

SHL Medical opens $220M SC factory, DHL acquires Cryopdp, AGC forms new division, new facilities for NBE, Siemens-Miko Ghana ...

There were nine PIPEs in the first quarter of 2025, compared to 34 in the same quarter of last year, according to data shared ...

FDA rejects Aldeyra's dry eye drug reproxalap again, seeks more data. Company plans 2025 resubmission. AbbVie partnership ...

MoonLake Immunotherapeutics gets $75M upfront from Hercules Capital in $500M financing deal; OSR Holdings to sell $80M in ...

A few cell and gene therapy biotechs are doing alright this week. The latest is Neurona Therapeutics, which exclusively told ...

What was once a promis­ing area of can­cer im­munother­a­py has had an­oth­er late-stage fail­ure. BeiGene said Thurs­day ...

Daymark Health launches with $11.5M from investors including Maverick Ventures and Yosemite to provide comprehensive care ...

A rapid cascade of seemingly conflicting details from President Donald Trump’s tariff announcement left large drugmakers on ...

The FDA on Thursday approved Amgen’s rare disease drug Uplizna in an autoimmune disorder, setting the stage for the therapy to gain a foothold in the rare disease market.